Skip to main content
. 2021 Jun 7;12(6):583. doi: 10.1038/s41419-021-03870-x

Fig. 1. Flowchart depicting study enrollment.

Fig. 1

A Screening of cross-oncogene in eight tumors. B The patients with prostate cancer enrolled in this study. BLCA bladder urothelial carcinoma, BRCA breast invasive carcinoma, ESCA esophageal carcinoma, KIRC kidney renal clear cell carcinoma, LIHC liver hepatocellular carcinoma, LUSC lung squamous cell carcinoma, PRAD prostate adenocarcinoma, STAD stomach adenocarcinoma, DEGs differentially expressed genes, RP radical prostatectomy, IHC Immunohistochemistry, OS overall survival, BCR biochemical recurrence.